|Articles|April 4, 2019

WCG Announces Acquisition of Analgesic Solutions

The WIRB-Copernicus Group’s Clinical Services Division announced the acquisition of Analgesic Solutions. Analgesic Solutions focuses on developing new pain medications and improving the quality of pain management clinical trials.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

© JHVEPhoto - © JHVEPhoto - stock.adobe.com

FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices

ByAndy Studna, Senior Editor

August 19th 2026

How to Accelerate Trial Timelines Without Compromising Safety or Data Quality

ByAmber Hill, PhD,Andy Studna, Senior Editor

August 19th 2026

ACT Brief: Phase I Back-Office Automation Priorities, Early Phase Data Interpretation Under Capital Pressure, and Syneos AI Ecosystem Expansion

ByAndy Studna, Senior Editor

August 19th 2026

© Shuo - © Shuo - stock.adobe.com

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

ByAndy Studna, Senior Editor

August 18th 2026

© putilov_denis - © putilov_denis - stock.adobe.com

Avoiding Pitfalls When Every Patient Becomes a Readout

ByDeborah Phippard, PhD

August 18th 2026

Trending on Applied Clinical Trials Online

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

ACT Brief: TrialBlazer Timeline Reductions and Operational Demands, Structural Trial Collaboration and Site Integration, and Henlius-Sandoz Biosimilars Partnership

One Clinical: Working Together to Advance Trial Collaboration

Avoiding Pitfalls When Every Patient Becomes a Readout

ACT Brief: Phase I Back-Office Automation Priorities, Early Phase Data Interpretation Under Capital Pressure, and Syneos AI Ecosystem Expansion